Why the study?
Does a combination of heparin and dihydroergotamine prevent postoperative fatal and non-fatal emboli in patients undergoing hip replacement?
Population
500 consecutive patients undergoing hip replacement
Design
Cohort
Follow-up
four weeks
Authors
Loading...
Low PE rates with heparin-dihydroergotamine after hip replacement support further study; leaves open efficacy versus controls pending randomized trials.
Does a combination of heparin and dihydroergotamine prevent postoperative fatal and non-fatal emboli in patients undergoing hip replacement?
The combination of heparin and dihydroergotamine appears effective for prophylaxis against pulmonary embolism after total hip replacement, with an acceptable risk of bleeding.
Vv et al. (1985) studied this question.